SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
02-Apr-24 4:54 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 01-Apr-24 | Payment of Exercise | 4,732 | $5.12 | $24,227.80 | (16%) 29.28K to 24.55K | |
02-Apr-24 4:54 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 31-Mar-24 | Option Exercise | 15,333 | -- | -- | 110% 13.95K to 29.28K | |
02-Nov-23 4:53 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 01-Nov-23 | Payment of Exercise | 6,301 | $2.22 | $13,988.20 | (31%) 20.25K to 13.95K | |
02-Nov-23 4:53 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 31-Oct-23 | Option Exercise | 18,875 | -- | -- | 1371% 1.38K to 20.25K | |
13-Jun-23 10:00 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 09-Jun-23 | Grant | 1,142 | -- | -- | 38% 3.0K to 4.14K | |
04-Apr-23 6:57 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 03-Apr-23 | Payment of Exercise | 623 | $2.58 | $1,607.34 | (31%) 2.0K to 1.38K | |
04-Apr-23 6:57 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 31-Mar-23 | Option Exercise | 2,000 | -- | -- | 100% 0 to 2.0K | |
30-Jun-22 6:32 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 29-Jun-22 | Grant | 1,750 | -- | -- | 100% 0 to 1.75K |